Risk for Alzheimer’s May Be Doubled By Common Prostate Cancer Treatment

Posted on by

A new study of 16,000+ men being treated for prostate cancer demonstrated that those who got any kind of androgen deprivation therapy had nearly twice the risk of developing Alzheimer’s over the next 2 ½ years as men getting other treatments. The result, based on the men’s medical records, is only a correlation, and not proof of causality, but is prompting cancer researchers to look more closely.

Links to the study and to articles about the study have been posted in Risk Factors:

Common Prostate Cancer Treatment May Double Risk for Alzheimer’s

Common prostate cancer treatment may double Alzheimer’s risk

Original article:
Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk [Abstract free; Full text: Paywall]

Category: Announcements